Novo Nordisk Inc et al v. McClain
| Novo Nordisk Inc and Novo Nordisk Pharma Inc |
| Alan McClain |
| 4:2023cv00969 |
| October 12, 2023 |
| US District Court for the Eastern District of Arkansas |
| James M Moody |
| Billy Roy Wilson |
| Constitutional - State Statute |
| 28 U.S.C. § 2201 Declaratory Judgement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 29, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 23 REPLY to Response to Motion re #12 MOTION to Dismiss Case as Frivolous MOTION to Dismiss filed by Alan McClain. (Rand, Kendall) |
Filing 22
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #21 Defendant's Motion for Leave to File Reply. Accordingly, Defendant's reply must be filed by 5 p.m., Tuesday, December 5, 2023. Signed by Judge Billy Roy Wilson on 11/29/23. (dmm)
|
| Filing 21 MOTION for Leave to File Reply To Plaintiffs' Response by Alan McClain (Rand, Kendall) |
| Filing 20 RESPONSE in Opposition re #12 MOTION to Dismiss Case as Frivolous MOTION to Dismiss Response in Opposition to Defendant's Motion to Dismiss filed by Novo Nordisk Inc, Novo Nordisk Pharma Inc. (Way, Mary) |
| Filing 19 INITIAL SCHEDULING ORDER: Rule 26(f) Conference to occur by 1/16/2024. Rule 26(f) Report due by 1/30/2024. Bench Trial set for 11/12/2024 at 9:30 AM in Little Rock Courtroom # A401 before Judge Billy Roy Wilson.Entered at the direction of the Court on 11/9/23. (mmb) |
| Filing 18 (This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) NOTICE OF REASSIGNMENT. Based on #17 Order, the Clerk's office has reassigned the case to Judge Billy Roy Wilson. (jak) |
|
Filing 17
ORDER finding this case closely related to Case 4:21-CV-00864 and for judicial economy should be transferred to the Honorable Billy Roy Wilson. Signed by Judge James M. Moody Jr. on 11/08/2023. (llg)
|
| Filing 16 BRIEF IN SUPPORT re #12 Motion to Dismiss filed by All Defendants. (Rand, Kendall) |
| Filing 15 RESPONSE in Opposition re #11 MOTION to Transfer Case Response in Opposition to Defendant's Motion to Transfer and Notice of Related Cases filed by Novo Nordisk Inc, Novo Nordisk Pharma Inc. (Way, Mary) |
| Filing 14 Mail Returned Undeliverable as to Nicole Bronnimann re 9 Order. (jbh) |
| Filing 13 Deficiency Letter from Clerk of Court notifying party that #12 Motion to Dismiss is not accompanied by a supporting brief (Local Rule 7.2(a)). (jak) |
| Filing 12 MOTION to Dismiss Case as Frivolous , MOTION to Dismiss () by Alan McClain (Rand, Kendall) |
| Filing 11 MOTION to Transfer Case by Alan McClain (Rand, Kendall) |
| Filing 10 ANSWER to Complaint by Alan McClain.(Rand, Kendall) |
|
Filing 9
(This is a TEXT ENTRY ONLY. There is no pdf document associated with this entry.) ORDER granting #5 MOTION for Leave to Appear pro hac vice by John Shakow, #6 MOTION for Leave to Appear pro hac vice by Nicole Bronnimann, and #7 MOTION for Leave to Appear pro hac vice by Ashley Parrish. Signed by Judge James M. Moody Jr. on 10/19/2023. (kog)
|
| Filing 8 NOTICE of Appearance by Kendall Booth Rand on behalf of All Defendants (Rand, Kendall) |
| Filing 7 MOTION for Leave to Appear pro hac vice by Ashley Parrish. Fee $100 receipt number AAREDC-4618222. Filed by Novo Nordisk Inc, Novo Nordisk Pharma Inc (Way, Mary) |
| Filing 6 MOTION for Leave to Appear pro hac vice by Nicole Bronnimann. Fee $100 receipt number AAREDC-4618213. Filed by Novo Nordisk Inc, Novo Nordisk Pharma Inc (Way, Mary) |
| Filing 5 MOTION for Leave to Appear pro hac vice by John Shakow. Fee $100 receipt number AAREDC-4618202. Filed by Novo Nordisk Inc, Novo Nordisk Pharma Inc (Way, Mary) |
| Filing 4 SUMMONS Returned Executed by Novo Nordisk Pharma Inc, Novo Nordisk Inc. Alan McClain served on 10/13/2023. (Way, Mary) |
| Filing 3 Corporate Disclosure Statement (Rule 7.1) by Novo Nordisk Inc, Novo Nordisk Pharma Inc (Way, Mary) |
| Filing 2 Deficiency Letter from Clerk of Court re #1 Complaint, notifying party that a Corporate Disclosure Statement was not filed with first appearance, pleading, petition, motion response, or other request (F.R.Cv.P. 7.1). (llg) |
| Filing 1 COMPLAINT FOR DECLARATORY AND INJUNCTIVE RELIEF against Alan McClain filed by Novo Nordisk Pharma Inc and Novo Nordisk Inc. (Filing Fee of $402 paid. Receipt Number LIT3906.) Summons issued and returned to counsel for service. (llg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Arkansas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
